{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:46:01Z","timestamp":1788435961733,"version":"build-2803163510"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0122764","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T19:30:08Z","timestamp":1428694208000},"page":"e0122764","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["15-Deoxy-\u039412,14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss"],"prefix":"10.1371","volume":"10","author":[{"given":"Ki Rim","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Kyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Taek","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Yoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"LJ Suva","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"RE Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","article-title":"Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy","volume":"10","author":"W Kozlow","year":"2005","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2013.10.006","article-title":"Targeting tumor-stromal interactions in bone metastasis","volume":"141","author":"M Esposito","year":"2014","journal-title":"Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jnci.2012.06.002","article-title":"Bone metastasis in breast cancer: the story of RANK-ligand","volume":"24","author":"HA Azim","year":"2012","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/ptr.4930","article-title":"The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction","volume":"27","author":"SK Lee","year":"2013","journal-title":"Phytother Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1634\/theoncologist.2007-0152","article-title":"Cancer treatment-induced bone loss: pathophysiology and clinical perspectives","volume":"13","author":"AM Brufsky","year":"2008","journal-title":"Oncologist"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1100\/tsw.2010.69","article-title":"Anti-inflammatory prostanoids: focus on the interactions between electrophile signaling and resolution of inflammation","volume":"10","author":"B Diez-Dacal","year":"2010","journal-title":"Scientific World Journal"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bcp.2011.07.100","article-title":"15-deoxy-\u0394<sup>12,14<\/sup>-prostaglandin J<sub>2<\/sub>, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling","volume":"82","author":"YJ Surh","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1568011043352902","article-title":"Effect of prostaglandins on the regulation of tumor growth","volume":"4","author":"S Ishihara","year":"2004","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2004.12.186","article-title":"Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax\/Bcl-xL and p21","volume":"328","author":"ZN Shen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1124\/mol.106.025759","article-title":"Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase\/nuclear factor-kappaB pathway","volume":"70","author":"A Ciucci","year":"2006","journal-title":"Mol Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.4049\/jimmunol.177.8.5068","article-title":"The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-\u0394<sup>12,14<\/sup>-prostaglandin J<sub>2<\/sub> and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms","volume":"177","author":"DM Ray","year":"2006","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1158\/1535-7163.MCT-08-0326","article-title":"Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer","volume":"7","author":"L Qiao","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2012-1313","article-title":"Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells","volume":"27","author":"S Kaikkonen","year":"2013","journal-title":"Mol Endocrinol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2011.01.004","article-title":"Induction of apoptosis by 15d-PGJ<sub>2<\/sub> via ROS formation: an alternative pathway without PPAR\u03b3 activation in non-small cell lung carcinoma A549 cells","volume":"94","author":"JJ Wang","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1023366117157","article-title":"PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro","volume":"79","author":"H Liu","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1196\/annals.1378.041","article-title":"Upregulation of VEGF by 15-deoxy-\u0394<sup>12,14<\/sup>-prostaglandin J<sub>2<\/sub> via heme oxygenase-1 and ERK1\/2 signaling in MCF-7 cells","volume":"1090","author":"EH Kim","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/carcin\/bgp012","article-title":"15-Deoxy-\u0394<sup>12,14<\/sup>-prostaglandin J<sub>2<\/sub> upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS","volume":"30","author":"DH Kim","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref20","first-page":"867180","article-title":"Thiazolidinediones on PPAR\u03b3: The roles in bone remodeling","volume":"2011","author":"W Wei","year":"2011","journal-title":"PPAR Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/SHK.0b013e3181cc0738","article-title":"Thiazolidinediones inhibit TNF-\u03b1-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1","volume":"33","author":"CR Yang","year":"2010","journal-title":"Shock"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bone.2007.11.016","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression","volume":"42","author":"H Hounoki","year":"2008","journal-title":"Bone"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1210\/endo.140.11.7116","article-title":"Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro","volume":"140","author":"R Okazaki","year":"1999","journal-title":"Endocrinology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"14388","DOI":"10.1074\/jbc.275.19.14388","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b3 pathway inhibits osteoclast differentiation","volume":"275","author":"G Mbalaviele","year":"2000","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.taap.2014.01.009","article-title":"Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment","volume":"275","author":"SY Park","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.fitote.2012.08.020","article-title":"Extract of Magnoliae Flos inhibits ovariectomy induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption","volume":"83","author":"AY Jun","year":"2012","journal-title":"Fitoterapia"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Park SI, Kim SJ, McCauley LK, Gallick GE. Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Curr Protoc Pharmacol. 2010;Chapter 14: Unit 14.15.","DOI":"10.1002\/0471141755.ph1415s51"},{"key":"ref28","first-page":"e4260","article-title":"Models of bone metastasis","volume":"67","author":"JP Campbell","year":"2012","journal-title":"J Vis Exp"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S8756-3282(02)00685-3","article-title":"Parathyroid hormone-related protein (PTHrP)-(1\u2013139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo","volume":"30","author":"TA Guise","year":"2002","journal-title":"Bone"},{"key":"ref30","first-page":"164","article-title":"Animal models for bone and joint disease. Ovariectomized and orchidectomized animals","volume":"21","author":"M Inada","year":"2011","journal-title":"Clin Calcium"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1158\/0008-5472.CAN-08-1078","article-title":"Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells","volume":"68","author":"J Pratap","year":"2008","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/1541-7786.MCR-10-0196","article-title":"TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells","volume":"9","author":"A Safina","year":"2011","journal-title":"Mol Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"46661","DOI":"10.1074\/jbc.M105816200","article-title":"Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad\/Ets synergism","volume":"276","author":"RK Lindemann","year":"2001","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"24571","DOI":"10.1074\/jbc.M202561200","article-title":"Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways","volume":"277","author":"SM Kakonen","year":"2002","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: Causes, consequences and therapeutic opportunities","volume":"2","author":"GR Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1026526703898","article-title":"PTH and PTHrP effects on the skeleton","volume":"1","author":"AC Karaplis","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2004.06.019","article-title":"A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells","volume":"35","author":"TL Andersen","year":"2004","journal-title":"Bone"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","article-title":"Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis","volume":"7","author":"AG Costa","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","article-title":"Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis","volume":"99","author":"F Daubin\u00e9","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/pros.20776","article-title":"Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions","volume":"68","author":"NK Thudi","year":"2008","journal-title":"Prostate"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3346\/jkms.2011.26.12.1569","article-title":"Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells","volume":"26","author":"J Jeong","year":"2011","journal-title":"J Korean Med Sci"},{"key":"ref42","first-page":"1569","article-title":"Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models","volume":"339","author":"KW Luo","year":"2013","journal-title":"Cancer Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ctrv.2012.02.002","article-title":"Antiresorptive therapies in oncology and their effects on cancer progression","volume":"38","author":"N Bundred","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"Suppl.3","key":"ref44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2010.533162","article-title":"Understanding and optimizing bone health in breast cancer","volume":"26","author":"TA Guise","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","article-title":"Osteoporosis and inflammation","volume":"65","author":"GR Mundy","year":"2007","journal-title":"Nutr Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0122764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T03:34:57Z","timestamp":1566531297000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0122764"}},"subtitle":[],"editor":[{"given":"Dominique","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0122764","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}